COO.US The Cooper Companies, Inc

Healthcare Health Care Equipment & Supplies USA Stocks
62.65 USD
Close of Nov 14, 2026
51.01 89.83
Market cap
USD 11.9B
P/E
21.4x
P/B
1.42x
ROE
7.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is COO.US undervalued?

Graham number
Price62.65
Graham value53.93
Premium16.2%

COO.US trades 16.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The Cooper Companies, Inc fundamental analysis

No fundamental analysis for The Cooper Companies, Inc yet.

The Cooper Companies, Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The Cooper Companies, Inc

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices…

Full company profile